Phase III randomized trial of Calendula Officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer

Journal of Clinical Oncology

Volumn 22, Issue 8, 2004, Pages 1447-1453

  Pommier, P ^a   Gomez, F ^a   Sunyach, M P ^a   D'Hombres, A ^a   Carrie, C ^a   Montbarbon, X ^a  

^a CENTRE LÉON BÉRARD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIAFINE; CALENDULA EXTRACT; TOPICAL AGENT; TROLAMINE; UNCLASSIFIED DRUG; ETHANOLAMINE DERIVATIVE; PLANT EXTRACT; TRIETHANOLAMINE;

ADJUVANT CHEMOTHERAPY; ARTICLE; BODY MASS; BREAST CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATITIS; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MARIGOLD; PAIN; PARTIAL MASTECTOMY; PATIENT SATISFACTION; PHASE 3 CLINICAL TRIAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; ACUTE DISEASE; ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; BREAST TUMOR; CALENDULA; COMPARATIVE STUDY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OINTMENT; RADIATION DERMATITIS; RADIATION INJURY; TOPICAL DRUG ADMINISTRATION;

ACUTE DISEASE; ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; BREAST NEOPLASMS; CALENDULA; COMBINED MODALITY THERAPY; ETHANOLAMINES; FEMALE; HUMANS; MIDDLE AGED; OINTMENTS; PLANT EXTRACTS; RADIATION INJURIES; RADIODERMATITIS; RADIOTHERAPY, ADJUVANT;

EID: 2342483078     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.07.063     Document Type: Article

References (24)

1. Duncan W, MacDougall RH, Kerr GR, et al: Adverse effect of treatment gaps in the outcome of radiotherapy for laryngeal cancer. Radiother Oncol 41:203-207, 1996
2. Robertson C, Robertson AG, Hendry JH, et al: Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers. Int J Radiat Oncol Biol Phys 40:319-329, 1998
3. Roy I, Fortin A, Larochelle M: The impact of skin washing with water and soap during breast irradiation: A randomized study. Radiother Oncol 58:333-339, 2001
4. Bostrom A, Lindman H, Swartling C, et al: Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: Results from a double-blind, randomized study. Radiother Oncol 59:257-265, 2001
5. Schmuth M, Wimmer MA, Hofer S, et al: Topical corticosteroid therapy for acute radiation dermatitis: A prospective, randomized, double-blind study. Br J Dermatol 146:983-991, 2002
6. Liguori V, Guillemin C, Pesce GF, et al: Double-blind, randomized clinical study comparing hyaluronic acid cream to placebo in patients treated with radiotherapy. Radiother Oncol 42: 155-161, 1997
7. Maiche A, Isokangas OP, Grohn P: Skin protection by sucralfate cream during electron beam therapy. Acta Oncol 33:201-203, 1994
8. Williams MS, Burk M, Loprinzi CL, et al: Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity. Int J Radiat Oncol Biol Phys 36:345-349, 1996
9. Fenig E, Brenner B, Katz A, et al: Topical Biafine and Lipiderm for the prevention of radiation dermatitis: A randomized prospective trial. Oncol Rep 8:305-309, 2001
10. Fisher J, Scott C, Stevens R, et al: Randomized phase III study comparing best supportive care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13. Int J Radiat Oncol Biol Phys 48:1307-1310, 2000
11. Heggie S, Bryant GP, Tripcony L, et al: A phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue. Cancer Nurs 25:442-451, 2002
12. Roy-Camille R: Biafine pour le traitement des plaies infectées et non infectées d'origine traumatique, in Clinical Trial, Hôpital de la Pitié Salpétrière, Paris, France, 1988
13. Coulomb B, Friteau L, Dubertret L: Biafine applied on human epidermal wounds is chemotactic for macrophages and increases the IL-1/ IL-6 ratio. Skin Pharmacol 10:281-287, 1997
14. Szumacher E, Wighton A, Franssen E, et al: Phase II study assessing the effectiveness of Biafine cream as a prophylactic agent for radiation-induced acute skin toxicity to the breast in women undergoing radiotherapy with concomitant CMF chemotherapy. Int J Radiat Oncol Biol Phys 51:81-86, 2001
15. Lievre M, Marichy J, Baux S, et al: Controlled study of three ointments for the local management of 2nd and 3rd degree burns. Clin Trials Metaanal 28:9-12, 1992
16. Cox JD, Stetz J, Pajak TF: Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341-1346, 1995
17. Serlin RC, Mendoza TR, Nakamura Y, et al: When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 61:277-284, 1995
18. Bijur PE, Silver W, Gallagher EJ: Reliability of the visual analog scale for measurement of acute pain. Acad Emerg Med 8:1153-1157, 2001
19. Gallagher EJ, Liebman M, Bijur PE: Prospective validation of clinically important changes in pain severity measured on a visual analog scale. Ann Emerg Med 38:633-638, 2001
20. Pathak MA: Sunscreens and their use in the preventive treatment of sunlight-induced skin damage. J Dermatol Surg Oncol 13:739-750, 1987
21. Pathak MA, Fanselow DL: Photobiology of melanin pigmentation: Dose/response of skin to sunlight and its contents. J Am Acad Dermatol 9:724-733, 1983
22. Fitzpatrick TB: The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 124:869-871, 1988
23. Tucker SL, Turesson I, Thames HD. Evidence for individual differences in the radiosensitivity of human skin. Eur J Cancer 28:1783-1791, 1992
24. Fernando IN, Ford HT, Powles TJ, et al: Factors affecting acute skin toxicity in patients having breast irradiation after conservative surgery: A prospective study of treatment practice at the Royal Marsden Hospital. Clin Oncol (R Coll Radiol) 8:226-233, 1996